Inicio・Lista de Acciones・Pharma Mar SA

P
Pharma Mar SA

Cerrado

83.25 -0.42

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

83.05

Máximo

83.35

Métricas clave
By Trading Economics
Ingresos	-2.6M -993K
Ventas	6.7M 50M
P/B Media del Sector	25.171 56.659
BPA	-0.056
Rentabilidad por dividendo	1.23
Margen de beneficios	-2.002
Empleados	505
EBITDA	-2.7M 9K

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+19.83% upside

Dividendos
By Acuity
Rentabilidad por dividendo Media del Sector	1.23% 2.18%
Próximas Ganancias	29 oct 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	27M 1.4B
Apertura anterior	83.67
Cierre anterior	83.25

Pharma Mar SA Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 sept 2026, 23:56 UTC

Correlated Moves

Macy's Inc shares are lower in after-market trading, influenced by a decline in Kohl's Corp and broader retail sector challenges.

4 sept 2026, 23:56 UTC

Southern Co. shares traded roughly flat in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

4 sept 2026, 23:56 UTC

Redwood Trust shares rose in after-market trading, amid rising Treasury yields and stable unemployment. The stock remains below its 20-day moving average.

4 sept 2026, 23:55 UTC

Mastercraft Boat Holdings Inc shares are higher in after-market hours. No specific news was identified to explain the movement.

4 sept 2026, 23:55 UTC

TE Connectivity PLC shares are higher in after-market trading. No specific company news was identified to explain this movement.

4 sept 2026, 23:55 UTC

Ameriprise Financial Inc shares are higher in after-market trading, influenced by stable labor market data and expectations for an interest rate hike.

4 sept 2026, 23:55 UTC

Incyte Corp shares are higher in after-market hours, reaching an early peak before settling back. No specific news was identified to explain the movement.

4 sept 2026, 23:55 UTC

Fastenal Co. shares moved higher in after-market trading, recovering from earlier losses amid rising Treasury yields and steady unemployment data.

4 sept 2026, 23:51 UTC

International Bancshares Corp. shares remained roughly flat during after-market hours, following four consecutive sessions of higher performance. No specific news was identified.

4 sept 2026, 23:51 UTC

Cytokinetics Inc shares are higher in after-market trading, reaching their highest cumulative return of the day, despite no specific news driving the move.

4 sept 2026, 23:51 UTC

Tecnoglass Inc shares are trading higher in after-market hours, marking five consecutive sessions of gains. No specific news was identified to explain the movement.

4 sept 2026, 23:51 UTC

CGI Inc shares are lower in after-market hours, continuing a decline since Friday's close. The stock remains significantly below its 20-day moving average.

4 sept 2026, 23:51 UTC

CME Group Inc shares are higher in after-market hours, reflecting strong performance as they approach the upper end of their one-month trading range.

4 sept 2026, 23:51 UTC

Axon Enterprise Inc shares are trading higher in after-market hours. No specific news was identified to explain this movement.

4 sept 2026, 23:51 UTC

Kohls Corp shares are lower in after-market hours amid weak trading and mixed economic signals, including rising unemployment and slowing wage growth.

4 sept 2026, 23:51 UTC

Nextera Energy Inc shares are lower in after-market hours, breaking a recent trend of higher daily closes amid a slight uptick in unemployment rates.

4 sept 2026, 23:51 UTC

EPR Properties shares are higher in after-market hours, reflecting unusual strength despite no specific company news amid mixed economic signals and interest rate expectations.

4 sept 2026, 23:51 UTC

Tapestry Inc shares are higher in after-market hours, recovering from an early dip. The stock remains below its 20-day moving average.

4 sept 2026, 23:51 UTC

ECB Set to Announce Deposit Facility Rate Hike Amid Inflation Concerns and Geopolitical Tensions on September 10, 2026.

4 sept 2026, 23:50 UTC

Wesco International Inc shares are higher in after-market hours, continuing a trend of recent gains and unusual trading activity noted earlier in the session.

4 sept 2026, 23:50 UTC

Weyerhaeuser Co shares are higher in after-market trading, reflecting an increase since Friday's close, despite remaining below the 20-day moving average.

4 sept 2026, 23:46 UTC

Antero Midstream Corp. shares showed little change during after-market hours, fluctuating within a narrow range and remaining above the 20-day moving average.

4 sept 2026, 23:46 UTC

Correlated Moves

US Bancorp shares are lower in after-market trading amid mixed macroeconomic signals and a decline in Live Oak Bancshares, reflecting broader market sentiments.

4 sept 2026, 23:46 UTC

Biogen Inc shares are lower in after-market hours, with no specific news driving the decline. Broader economic signals are contributing to market uncertainty.

4 sept 2026, 23:46 UTC

Enovix Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. Broader market dynamics influenced investor sentiment.

4 sept 2026, 23:45 UTC

Hershey Co. shares gained in after-market trading, reflecting routine performance amid broader market dynamics, despite earlier fluctuations after Friday's close.

4 sept 2026, 23:45 UTC

First American Financial shares higher in after-market trading, reflecting broader market movements amid shifting expectations for interest rates and recent economic data.

4 sept 2026, 23:45 UTC

Iron Mountain Inc is trading lower in after-market hours, with no specific news identified. The stock remains near its one-month low and below its 20-day moving average.

4 sept 2026, 23:45 UTC

Social Media

NIO Inc. CEO William Li discussed "operational quality" in a closed-door meeting. Shares traded roughly flat during after-market hours following the discussion.

4 sept 2026, 23:45 UTC

Lucid Group Inc. shares are trading lower in after-market hours, continuing a trend of weakness amid broader market declines and remaining below the 20-day moving average.

Comparación entre iguales

Cambio de precio

Pharma Mar SA previsión

Precio Objetivo

By TipRanks

19.83% repunte

Estimación a 12 Meses

Media 100.002 EUR 19.83%

Máximo 100 EUR

Mínimo 100 EUR

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pharma Mar SA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

Comprar

Mantener

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Pharma Mar SA Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pharma Mar SA

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.